BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200504
DTEND;VALUE=DATE:20200508
DTSTAMP:20260515T075007
CREATED:20191215T133346Z
LAST-MODIFIED:20191215T133426Z
UID:23365-1588550400-1588895999@www.pharmajournalist.com
SUMMARY:NASH Summit Boston
DESCRIPTION:The NASH Summit offers a wide range of cutting-edge debates across 4 conference tracks: discovery\, translational\, non-invasive biomarker and clinical drug development\, in addition to a selection of workshops and seminars. This convivial discussion and networking forum has an extensive program set to help you approach your pipeline for the upcoming year. \n \nJoin 80+ speakers\, including our conference Chair Jason Campagna\, Senior Vice President & Global NASH Lead at Intercept\, and 350+ attendees as the community comes together again by addressing their challenges and the consequences of change in the NASH market. \n\nEstablish a plan of action to optimize candidate success by evaluating advances and difficulties and learn from the community’s experience\nTranslate anti-fibrotic efficacy into the clinic by learning about ground-breaking preclinical modalities\nUse the latest practical insights into hepatocyte differentiation to improve your target identification by understanding its impact on immune cells\, ductular reaction and fibrosis\nExamine the payer’s thoughts on the need to biopsy and assess the clinical utility of non-invasive diagnostics in the normal algorithm of care\nConnect NASH reduction in phase 2 and NASH resolution in phase 3 while justifying a systemic approach to address NASH in combination\, as a manifestation of wider metabolic dysfunction\n\nDownload the full event guide or get in touch today for the agenda and speaker line-up!
URL:https://www.pharmajournalist.com/event/nash-summit-boston/
LOCATION:50 Park Plaza at Arlington Street\, Boston\, MA\, 02116-3912\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200511
DTEND;VALUE=DATE:20200513
DTSTAMP:20260515T075007
CREATED:20180202T092329Z
LAST-MODIFIED:20200319T094546Z
UID:9152-1589155200-1589327999@www.pharmajournalist.com
SUMMARY:SMi’s 20th Annual Pain Therapeutics Conference
DESCRIPTION:SMi’s 20th Annual Pain Therapeutics Conference\nDiscover Cutting Edge Research and Novel Therapeutics in the Pipeline \nConference: 11 and 12 May 2020\nLocation: REMOTE ACCESS ONLY\nWebsite: http://www.pain-therapeutics.co.uk/PharmaJournWL \nAnnouncement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.pain-therapeutics.co.uk \nThe price to be a part of this conference is £999 (remote access) and registration is available via the conference website at www.pain-therapeutics.co.uk \nThe 20th Annual Conference will overview the current state of pain treatment starting with research essentials including choosing the right preclinical models to overviewing clinical success up to date\, highlighting cutting-edge research and evaluating the potential of drug candidates in the pipelines of leading pharmaceuticals. \n \nThis year we are introducing the Pain Research Essentials theme to closely observe analgesics drug development from a preclinical point of view. Within this theme talks will address the latest biomarker discoveries\, bridging the translational gap\, differences of pain pathology across sexes and consequently\, the need for distinct gender animal models. This will be topped with a panel discussion around novel drug targets in neuropathic pain treatment.  \nPresentations on clinical stage research will highlight current struggles of opioid-based treatments and discuss results of treatments with non-opioid targets; such as the recently researched cannabinoid receptor 2\, nociception/orphanin FQ peptide (NOP) receptor\, ENKephalinase and NGF receptors. Furthermore\, neuro-immune interactions and their role in pain pathology will be discussed as an anticipated approach for providing more effective therapy for chronic pain. Additionally\, the therapeutic efficacy of neurotoxins will be addressed exploring novel botulinum-based constructs.  \nJoin SMi’s leading Pain Therapeutics Conference which will explore the cutting-edge research of novel therapeutics in the pipeline of leading pharmaceutical companies and discuss solutions for the challenges of understanding pain as a heterogenous disease and the diverse treatment approaches it requires. \nEvent Hashtag: #SMiPain \nView the full agenda: http://www.pain-therapeutics.co.uk/PharmaJournWL \nWHO SHOULD ATTEND \nChief Executive Officer\, Chief Scientific Officers\, Chief Medical Officers\, Managing Directors\, CEO\, Head of Department\, Principal Research Scientists\, Clinical lead\, Clinical Operations in the following fields: \n\nPain and Migraine\nInflammation\nChronic Pain\nNeuropathic Pain\nAnalgesic pre-clinical development\nAnaesthesia and Pain Management\nCNS clinical trials\nIon Channel Pharmacology\nPharmacology Intelligence\nTranslational science\nDrug development\nExploratory development\n\nEARLY BIRD-RATES \n\nBOOK BY 28TH FEBRUARY AND SAVE £200\nBOOK BY 31ST MARCH AND SAVE £100
URL:https://www.pharmajournalist.com/event/smi-pain-therapeutics-conference/
LOCATION:REMOTE ACCESS ONLY
ORGANIZER;CN="SMi Group Ltd":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200511
DTEND;VALUE=DATE:20200513
DTSTAMP:20260515T075007
CREATED:20180307T074833Z
LAST-MODIFIED:20200323T125717Z
UID:11545-1589155200-1589327999@www.pharmajournalist.com
SUMMARY:Highly Potent Active Pharmaceutical Ingredients (HPAPI)
DESCRIPTION:SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020. \nAnnouncement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.highlypotentapi.com \nThe price to be a part of this conference is £999 (remote access) and registration is available via the conference website www.highlypotentapi.com \n \nHPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology\, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits\, assessing hazards\, implementing risk procures\, translating risk assessment into facility engineering\, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines. \nAttend the conference and join our networking platform for industry professionals to provide you with the expertise to overcome the challenges of the HPAPI industry. \nNetwork and learn from leading professionals such as: \nCHAIR FOR 2020 – Justin Mason-Home\, Director\, HPAPI Project Services Limited \nKEY SPEAKERS INCLUDE: \nPascal Michoux\, Vice President\, Global EHS Teva api & Biologics\, teva API Italy\nWilliam Hawkins\, Manager Occupation Toxicology\, GsK\nBrian Edwards\, Chair\, Pharmaceutical Human Factors Group\, CIeHf\nThomas Adam\, Head of GQA Chemical APIs\, Bayer AG\nIldikó Ziegler\, QA Manager\, Gedeon Richter\nFrancois D’Hooge\, ADC Project Manager\, Gamamabs Pharma\nAndreas Schreiner\, Head of Validation\, Novartis \nFEATURED HIGHLIGHTS: \n\nExplore HPAPI manufacturing with 8 big pharma from both the toxic substance and the employees’ perspective\nGain better understanding of human factors and ergonomics aspects and their role in improving production performance with the Chartered Institute of Ergonomics and Human Factors\nDeep dive into the oncology market and ADC production\, the main driver of the HPAPI industry\nLearn what it takes to create a safety company culture and how to better train your employees on risk perception\n\nView the full agenda: www.highlypotentapi.com \nContact Info: \nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/highly-potent-active-pharmaceutical-ingredients-hpapi/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd.":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200513
DTEND;VALUE=DATE:20200515
DTSTAMP:20260515T075007
CREATED:20190912T073738Z
LAST-MODIFIED:20190912T073738Z
UID:22362-1589328000-1589500799@www.pharmajournalist.com
SUMMARY:4th Annual Global Clinical Trials Connect 2020 - Collaboration\, Innovation and Enhancing Quality in Clinical Trials
DESCRIPTION:The 4th Annual Global Clinical Trials Connect 2020 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from clinical trials community from around the globe who are focused on learning more about clinical research\, clinical trials planning and management. \nKey Highlights \n\nPatient Recruitment and Site selection\nInnovative trial designs\nPartnership & Collaboration – Sponsors\, CROs\, Sites and External Vendors\nPatient centric clinical trials\nNew innovations in Patient Recruitment planning and execution on a clinical trial\nOutsourcing strategies and models\nElectronic Clinical Outcome Assessment and Electronic Patient Reported Outcome\nStreamlined IRT development process\nPharmacovigilance & Clinical Trials\nPost-Clinical Trial closed communities\nHow to future proof your clinical operations\nImplementing Risk Based Monitoring\nStreamlining R&D and lower costs in clinical trials\nAdaptive Trial Model\nClinical Trial Auditing\nReal World Clinical Trial Strategies\nData Quality & Technology\nClinical Data Strategy & Analytics\nClinical Technology and Driving Innovation\nM-Health\, Wearable and Consumer Technology\nBig-Data\, IoT and Artificial Intelligence Technology in Clinical trials\nBlockchain technology for improving clinical research quality
URL:https://www.pharmajournalist.com/event/4th-annual-global-clinical-trials-connect-2020-collaboration-innovation-and-enhancing-quality-in-clinical-trials/
LOCATION:Holiday Inn London – Kensington High St. Wrights Ln\, Kensington\, London W8 5SP\, UK
ORGANIZER;CN="Corvus Global Events":MAILTO:info@corvusglobalevents.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200519
DTEND;VALUE=DATE:20200521
DTSTAMP:20260515T075007
CREATED:20200318T114228Z
LAST-MODIFIED:20200318T114228Z
UID:24652-1589846400-1590019199@www.pharmajournalist.com
SUMMARY:Outsourcing in Clinical Trials East Coast
DESCRIPTION:Discover effective strategies for outsourcing clinical trial operations to ensure studies run smoothly and within budget \n\nArena International are delighted to announce Outsourcing in Clinical Trials East Coast will be returning to King of Prussia in May for its 11th Annual event!\n\nThe 2020 programme will feature a range of speakers from the likes of GlaxoSmithKline\, Novartis\, Pfizer\, BMS any many more\, who through a variety of interactive session formats will offer insight on promoting successful collaboration between the clinical trials community. Attendees will have the opportunity of taking part in sessions across 3 stages\, each focusing on a different topic area. Whether your role is Clinical Operations\, Technology & Innovation or Clinical Data Management this event can not be missed\n\nWe look forward to seeing you there!
URL:https://www.pharmajournalist.com/event/outsourcing-in-clinical-trials-east-coast/
LOCATION:Valley Forge Casino Resort – 1160 1st Ave\, King of Prussia\, PA 19406\, United States
ORGANIZER;CN="Arena International":MAILTO:kadin.luong@arena-international.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200525
DTEND;VALUE=DATE:20200531
DTSTAMP:20260515T075007
CREATED:20200511T104035Z
LAST-MODIFIED:20200511T104403Z
UID:25449-1590364800-1590883199@www.pharmajournalist.com
SUMMARY:Digital Health Online Summit
DESCRIPTION:The healthcare industry will never be the same after COVID19. \nHealthcare professionals need to stay aware of the latest digital health activities and keep learning from leading organizations. \n \nDigital Health Online Summit is a 6-day virtual summit\, providing a comprehensive overview of the current digital health activities\, and equipping health professionals with strategies and tactics\, examples and guidelines for a successful healthcare transformation. \nThis online summit will provide you with timely insights into the following areas: \n\nDigital Health – Current Activities in different organizations\nSmart Care\, Patient Centricity and Engagement\nTransformation with VR/AR\, Voice Tech\, IoT\, Wearables\nBig Data\, AI and Machine Learning\nThe digital mindset transformation\nPatient staff engagement and culture change\nNew Horizon\, Innovation and Tomorrow’s Perspectives\n\nWithin each topic\, there will be 5-9 speaking sessions\, using case studies and bringing practical examples. The summit will gather 40 expert speakers from great companies and associations from all around the world\, including Europe\, North America and Australia. \nWhile the standard events require a lot of time\, effort\, logistics\, and significant expenses for travel and accommodation\, Digital Health Online Summit takes advantage of today’s technologies and provides the best content for professionals from all around the world. \nTo mention just some of the speaker’s companies: United Health Group\, HNS\, Dignity Health\, European Health Management Association\, WONCA\, Stanford Virtual Human Interaction Lab\, XpertCare Inc.\, Seton Health Alliance\, Deloitte\, KPMG\, Mednax\, Crossroads Hospice & Palliative Care\, CitiusTech\, Partners HealthCare\, Peninsula Regional Health System\, Philips\, Ramsay Santé and others. \nThis is a great possibility to learn directly from C-Suite executives with unique and timely insights about the digital shift towards better health services. \nHere are just some of the case studies and presentations: \n➤ Visions and Strategies for Virtual care services\n➤ Current Challenges of Digitalization in the Healthcare Industry\n➤ Key components of a successful digital transformation strategy\n➤ How to keep the conversation open with HCPs while they are not available (COVID-19 crisis time)\n➤ Frontline digital healthcare strategy – from business as usual to crisis management\n➤ Digital when possible – physical when needed\n➤ Personalized\, digitally-supported\, out- of-hospital care: A patient case study\n➤Digital Therapeutics: Just Like a pill?\n➤ Innovation in times of a global crisis \nAnd much\, much more. \nFor our members and network\, we have FREE REGISTRATIONS to this great online summit. \nGet your FREE PASS here >> https://www.digitalhealthonlinesummit.com/?utm_source=partner \nHope you can join the event!
URL:https://www.pharmajournalist.com/event/digital-health-online-summit/
LOCATION:Online
ORGANIZER;CN="Digital Health Online Summit":MAILTO:ilya@digitalhealthonlinesummit.com
END:VEVENT
END:VCALENDAR